会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • CD43:MODULATORS OF MAST CELL DEGRANULATION
    • CD43:MASTCELL DEGRANULATION的调节剂
    • WO2002101071A2
    • 2002-12-19
    • PCT/US2002/017418
    • 2002-05-31
    • RIGEL PHARMACEUTICALS, INC.BENNETT, MarkHOLLAND, SachaROSSI, Alex
    • BENNETT, MarkHOLLAND, SachaROSSI, Alex
    • C12Q
    • C07K14/70596A61K38/00
    • The present invention relates to regulation of IgE-receptor-mediated mast cell degranulation. More particularly, the present invention is directed to nucleic acids encoding CD43 (also called leukosialin or leukocyte large sialoglycoprotein), which is involved in modulation of IgE-receptor-mediated mast cell degranulation. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions, antibodies, siRNA, antisense nucleic acids, and ribozymes, that modulate IgE-receptor-mediated mast cell degranulation via modulation of CD43 and CD43-related signal transduction; as well as to the use of expression profiles and compositions in diagnosis and therapy related to diseases such as allergies and asthma.
    • 本发明涉及IgE受体介导的肥大细胞脱粒的调节。 更具体地,本发明涉及编码CD43(也称为白血球蛋白或白细胞大唾液酸糖蛋白)的核酸,其涉及调节IgE受体介导的肥大细胞脱粒。 本发明还涉及用于鉴定和使用通过调节CD43和CD43相关信号转导调节IgE受体介导的肥大细胞脱粒的试剂,包括小分子化学组合物,抗体,siRNA,反义核酸和核酶的方法; 以及在与诸如过敏和哮喘等疾病相关的诊断和治疗中使用表达谱和组合物。